Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer
Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer is organized by Physicians' Education Resource, LLC (PER).
Release Date: May 10, 2023
Expiration Date: May 10, 2024
Description:
This video-based program is designed for healthcare professionals to explore the management of hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer through a unique perspective, putting the patient voice front and center. A patient and their caregiver will lend their expertise to this program by sharing their journey living with HR+/HER2- metastatic breast cancer. This online activity focuses on the efficacy and safety of therapies recommended for the treatment of this disease in the metastatic setting, with panel discussions on the role of shared decision making and multidisciplinary management strategies to optimize patient outcomes.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Evaluate clinical trial results concerning the use of current and emerging therapeutic agents for HR+/HER2- advanced or metastatic breast cancer (MBC), including CDK4/6 inhibitors, I3K/mTOR inhibitors, PARP inhibitors, and antibody-drug conjugates
• Individualize treatment care plans for patients with HR+/HER2- MBC by incorporating clinical trial evidence, expert guidelines, biomarkers, tumor features, patient characteristics, and comorbidities, as appropriate
• Discuss strategies for minimizing and managing adverse events associated with treatments for HR+/HER2- MBC, in order to optimize the therapeutic ratio
• Develop strategies to facilitate effective communication with patients, improve education regarding treatment expectations, enhance shared decision-making, and address potential disparities and barriers to care.